サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1563085

エビ疾病診断市場：世界の産業分析、規模、シェア、成長、動向、2024～2033年予測

Shrimp Disease Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

出版日
ページ情報
英文 215 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
エビ疾病診断市場：世界の産業分析、規模、シェア、成長、動向、2024～2033年予測
出版日: 2024年09月25日
発行: Persistence Market Research
ページ情報: 英文 215 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Researchはこのほど、世界のエビ疾患診断市場に関する包括的なレポートを発表し、市場促進要因・動向・機会・課題など、主要な市場力学を詳細に分析しました。この詳細なレポートでは、市場構造と予測期間における成長の可能性について明らかにしています。

主要洞察

  • エビの疾病診断市場規模（2024年）：5億90万米ドル
  • 予測市場規模（2033年）：8億2,100万米ドル
  • 世界市場成長率（CAGR 2024～2033年）：5.6%

エビ疾患診断薬市場-調査範囲

エビ疾病診断市場は、養殖に不可欠なエビに影響を与える様々な病気の診断テストの開発と応用に焦点を当てています。この市場には、分子診断、免疫診断、生化学試験など様々な診断方法が含まれます。主要成長促進要因としては、世界のエビ需要の増加、養殖活動の活発化、サステイナブルエビ養殖の必要性などが挙げられます。

市場促進要因：

世界のエビ疾病診断市場の成長を牽引している主要要因はいくつかあります。消費と輸出の増加に後押しされたエビの世界需要の増加は、その大きな要因となっています。さらに、養殖業の生産性と収益性を確保するためにエビの個体数を健全に維持する必要性が、診断ソリューションの採用を後押ししています。エビ養殖業者における疾病管理と予防に対する意識の高まりも市場の成長を支えています。

市場抑制要因：

エビ疾病診断市場は成長の可能性があるにもかかわらず、いくつかの課題に直面しています。高度な診断技術にかかるコストが高いため、特に小規模農業従事者での導入が制限される可能性があります。さらに、標準化された試験プロトコルの欠如や、利用可能な診断ソリューションの認知度の低さは、市場拡大の妨げとなる可能性があります。規制上の課題や、エビの病気の流行が地域によって異なることも、大きな障壁となる可能性があります。

市場機会：

エビ疾病診断市場は、特に技術の進歩によって大きな成長機会をもたらしています。PCRベースの試験など、分子診断学の革新は病気の検出能力を高めると予想されます。診断会社と水産養殖の利害関係者とのコラボレーションは、技術革新を促進し、市場範囲を拡大することができます。さらに、費用対効果が高く、使いやすい診断ツールを開発するための研究開発への投資が増加しており、成長の機会がさらに広がっています。

本レポートで扱う主要質問

  • 世界のエビ疾病診断市場を牽引する主要要因は何か？
  • エビ疾病診断の導入が最も進んでいるのはどの地域か、またこの成長に影響を与えている動向は何か？
  • 診断技術の進歩は競合情勢にどのような影響を与えているか？
  • エビ疾病診断市場における主要企業はどこか、また市場ポジションを維持するためにどのような戦略をとっているのか？
  • 世界のエビ疾患診断市場における新たな動向と将来性は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/ 分類
  • 市場の定義/ 範囲/ 制限
  • 包含と除外

第3章 主要な市場動向

  • 市場に影響を与える主要動向
  • 市場の革新/開発動向

第4章 重要成功要因

  • 製品採用分析
  • 最近の製品承認
  • 規制状況
  • 償還シナリオ
  • サプライチェーン分析
  • ポーターの分析
  • PESTLE分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因-関連性と影響
  • 市場力学

第6章 COVID-19危機分析

  • COVID-19と影響分析
    • 試薬キット
    • 病気別
    • エンドユーザー別
    • 国別
  • 2024年の市場シナリオ

第7章 世界市場の需要（金額または規模、100万米ドル）分析

  • 過去の市場金額（100万米ドル）分析、2019～2023年
  • 市場分類別の現在と将来の市場規模（100万米ドル）の分析と予測、2024～2033年
    • 前年比成長動向分析
    • 絶対的収益機会

第8章 試薬キット別の世界の市場分析

  • イントロダクション/主要調査結果
  • 2019～2023年における試薬キット別の市場規模（100万米ドル）の実績の分析
  • 試薬キット別の現在と将来の市場規模（100万米ドル）分析と予測、2024～2033年
    • 迅速試験キット
    • アッセイベースのキット
  • 試薬キット別市場の魅力分析

第9章 疾病別の世界の市場分析

  • イントロダクション/主要調査結果
  • 2019～2023年における疾病別の市場規模（100万米ドル）の実績の分析
  • 疾病別の現在と将来の市場規模（100万米ドル）分析と予測、2024～2033年
    • WSSV（白斑症候群ウイルス）
    • TSV（タウラ症候群ウイルス）
    • YHV/GAV（イエローヘッド/ギル関連ウイルス）
    • IHHNV（感染性皮下組織と造血器ウイルス）
    • HPV（肝膵パルボウイルス）
    • MBV（モノドンバキュロウイルス）
    • IMNV（伝染性筋壊死ウイルス）
    • NHP-B（壊死性肝膵炎細菌）
    • MoV（モリリアンウイルス）
    • 早期死亡症候群（EMS）
  • 疾病別市場の魅力分析

第10章 エンドユーザー別の世界の市場分析

  • イントロダクション/主要調査結果
  • エンドユーザー別市場規模（100万米ドル）の過去分析、2019～2023年
  • エンドユーザー別の現在と将来の市場規模（100万米ドル）の分析と予測、2024～2033年
    • 漁業
    • 水産養殖研究所
    • 海洋研究所
    • 教育研究機関
    • その他
  • エンドユーザー別市場の魅力分析

第11章 地域別の世界の市場分析

  • イントロダクション/主要調査結果
  • 2019～2023年における地域別市場規模（100万米ドル）の過去分析
  • 地域別の現在と将来の市場規模（100万米ドル）分析と予測、2024～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ
  • 地域別市場の魅力分析

第12章 北米市場分析

第13章 ラテンアメリカ市場分析

第14章 欧州市場分析

第15章 東アジア市場分析

第16章 南アジア市場分析

第17章 オセアニア市場

第18章 中東・アフリカ市場分析

第19章 市場構造分析

  • 企業階層別市場分析
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第20章 競合分析

  • 競合ダッシュボード
  • ブランディングとプロモーション戦略
  • 主要開発分析
  • 競合の詳細
    • HiMedia Laboratories
    • HiMedia Laboratories
    • Speedy Assay Sdn Bhd
    • REAGEN LLC
    • FUJIKURA KASEI CO., LTD.
    • GeneReach Biotechnology Corp.
    • Thermo Fisher Scientific
    • Lab-Ind Resource Sdn Bhd.
    • SUREBIO
    • Auro Biotechnologies Pvt. Ltd.

第21章 使用される仮定と頭字語

第22章 調査手法

目次
Product Code: PMRREP29626

Persistence Market Research has recently released a comprehensive report on the global Shrimp Disease Diagnostics Market, providing an in-depth analysis of key market dynamics, including drivers, trends, opportunities, and challenges. This detailed report sheds light on the market structure and growth potential over the forecast period.

Key Insights:

  • Shrimp Disease Diagnostics Market Size (2024E): US$500.9 million
  • Projected Market Value (2033F): US$821 million
  • Global Market Growth Rate (CAGR 2024 to 2033): 5.6%

Shrimp Disease Diagnostics Market - Report Scope:

The Shrimp Disease Diagnostics Market focuses on the development and application of diagnostic tests for various diseases affecting shrimp, which are vital to aquaculture. The market encompasses various diagnostic methods, including molecular diagnostics, immunodiagnostics, and biochemical tests. Key growth drivers include the rising global demand for shrimp, increasing aquaculture activities, and the need for sustainable shrimp farming practices.

Market Growth Drivers:

Several key factors are driving the growth of the global Shrimp Disease Diagnostics Market. The increasing global demand for shrimp, fueled by rising consumption and exports, is a significant contributor. Furthermore, the need to maintain healthy shrimp populations to ensure productivity and profitability in aquaculture is pushing the adoption of diagnostic solutions. Increased awareness of disease management and prevention among shrimp farmers also supports market growth.

Market Restraints:

Despite its growth potential, the Shrimp Disease Diagnostics Market faces several challenges. High costs associated with advanced diagnostic technologies can limit their adoption, especially among small-scale farmers. Additionally, a lack of standardized testing protocols and limited awareness of available diagnostic solutions can hinder market expansion. Regulatory challenges and the varying prevalence of shrimp diseases across regions may also pose significant barriers.

Market Opportunities:

The Shrimp Disease Diagnostics Market presents substantial growth opportunities, particularly through advancements in technology. Innovations in molecular diagnostics, such as PCR-based tests, are expected to enhance disease detection capabilities. Collaborations between diagnostic companies and aquaculture stakeholders can drive innovation and expand market reach. Furthermore, increasing investment in research and development to create cost-effective and user-friendly diagnostic tools presents further opportunities for growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the global Shrimp Disease Diagnostics Market?
  • Which regions are witnessing the highest adoption of shrimp disease diagnostics, and what trends are influencing this growth?
  • How are advancements in diagnostic technologies impacting the competitive landscape?
  • Who are the leading players in the Shrimp Disease Diagnostics Market, and what strategies are they implementing to maintain their market positions?
  • What are the emerging trends and future prospects in the global Shrimp Disease Diagnostics Market?

Competitive Intelligence and Business Strategy:

Leading players in the Shrimp Disease Diagnostics Market, including companies like IDEXX Laboratories, Neogen Corporation, and Thermo Fisher Scientific, are focusing on innovation, research and development, and strategic partnerships to strengthen their market positions. These companies are investing in the development of advanced diagnostic solutions and enhancing their distribution networks. Collaborations with aquaculture stakeholders, research institutions, and regulatory bodies are crucial for market penetration and sustained growth. Ensuring compliance with global regulatory standards and addressing the unique needs of shrimp farmers will help these companies maintain a competitive edge and achieve long-term success in the Shrimp Disease Diagnostics Market.

Key Companies Profiled:

  • HiMedia Laboratories
  • HiMedia Laboratories
  • Speedy Assay Sdn Bhd
  • REAGEN LLC
  • FUJIKURA KASEI CO., LTD.
  • GeneReach Biotechnology Corp.
  • Thermo Fisher Scientific
  • Lab - Ind Resource Sdn Bhd.
  • SUREBIO
  • Auro Biotechnologies Pvt. Ltd.

Key Segments Covered in Shrimp disease diagnostics Industry Research

Reagent:

  • Rapid Testing Kits
  • Assay Based Kits

Disease:

  • WSSV (White Spot Syndrome Virus)
  • TSV (Taura Syndrome Virus)
  • YHV/GAV (Yellow Head/Gill Associated Virus)
  • IHHNV (Infectious Hypodermal and Hematopoietic Virus)
  • HPV (Hepatopancreatic Parvovirus)
  • MBV (Monodon Baculovirus)
  • IMNV (Infectious Myonecrosis Virus)
  • NHP-B (Necrotising Hepatopancreatitis Bacteria)
  • MoV (Mourilyan Virus)
  • Early Mortality Syndrome (EMS)

End User:

  • Fisheries
  • Aquaculture Laboratories
  • Marine Laboratories
  • Education and Research Institutes

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Market Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption Analysis
  • 4.2. Recent Product Approvals
  • 4.3. Regulatory Landscape
  • 4.4. Reimbursement Scenario
  • 4.5. Supply Chain Analysis
  • 4.6. Porter's Analysis
  • 4.7. PESTLE Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP outlook
    • 5.1.2. Global Healthcare Expenditure Outlook
    • 5.1.3. Global Animal Diagnostics Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Growing Healthcare Expenditure
    • 5.2.2. Historic and Current Revenue of Key Players
    • 5.2.3. Increasing Adoption of Diagnostic Tools
    • 5.2.4. Rising Incidences of Infectious Diseases
    • 5.2.5. Introduction of New and Advance Reagent Kits and Devices
    • 5.2.6. High Cost of Diagnostic kits
    • 5.2.7. Increasing Research and Development Activities to Develop Diagnostic Tools
    • 5.2.8. Strategic Collaboration Among Players
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Reagent Kits
    • 6.1.2. By Disease
    • 6.1.3. By End User
    • 6.1.4. By Country
  • 6.2. 2024 Market Scenario

7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 7.2. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Reagent Kits

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis by Reagent Kits, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Reagent Kits, 2024-2033
    • 8.3.1. Rapid Testing Kits
    • 8.3.2. Assay Based Kits
  • 8.4. Market Attractiveness Analysis by Reagent Kits

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Disease

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis by Disease, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Disease, 2024-2033
    • 9.3.1. WSSV (White Spot Syndrome Virus)
    • 9.3.2. TSV (Taura Syndrome Virus)
    • 9.3.3. YHV/GAV (Yellow Head/Gill Associated Virus)
    • 9.3.4. IHHNV (Infectious Hypodermal and Hematopoietic Virus)
    • 9.3.5. HPV (Hepatopancreatic Parvovirus)
    • 9.3.6. MBV (Monodon Baculovirus)
    • 9.3.7. IMNV (Infectious Myonecrosis Virus)
    • 9.3.8. NHP-B (Necrotising Hepatopancreatitis Bacteria)
    • 9.3.9. MoV (Mourilyan Virus)
    • 9.3.10. Early Mortality Syndrome (EMS)
  • 9.4. Market Attractiveness Analysis by Disease

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2024-2033
    • 10.3.1. Fisheries
    • 10.3.2. Aquaculture Laboratories
    • 10.3.3. Marine Laboratories
    • 10.3.4. Education and Research Institutes
    • 10.3.5. Others
  • 10.4. Market Attractiveness Analysis by End User

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis, by Region, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2024-2033
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. East Asia
    • 11.3.5. South Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East & Africa
  • 11.4. Market Attractiveness Analysis by Region

12. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Reagent Kits
    • 12.3.3. By Disease
    • 12.3.4. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Reagent Kits
    • 12.4.3. By Disease
    • 12.4.4. By End User
  • 12.5. Market Trends
  • 12.6. Key Market Participants - Intensity Mapping
  • 12.7. Drivers and Restraints - Impact Analysis
  • 12.8. Country Level Analysis & Forecast
    • 12.8.1. U.S. Market
      • 12.8.1.1. Introduction
      • 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.1.2.1. By Reagent Kits
        • 12.8.1.2.2. By Disease
        • 12.8.1.2.3. By End User
    • 12.8.2. Canada Market
      • 12.8.2.1. Introduction
      • 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.2.2.1. By Reagent Kits
        • 12.8.2.2.2. By Disease
        • 12.8.2.2.3. By End User

13. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. Mexico
      • 13.3.1.2. Brazil
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Reagent Kits
    • 13.3.3. By Disease
    • 13.3.4. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Reagent Kits
    • 13.4.3. By Disease
    • 13.4.4. By End User
  • 13.5. Market Trends
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. Mexico Market Analysis
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Reagent Kits
        • 13.8.1.2.2. By Disease
        • 13.8.1.2.3. By End User
    • 13.8.2. Brazil Market Analysis
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Reagent Kits
        • 13.8.2.2.2. By Disease
        • 13.8.2.2.3. By End User
    • 13.8.3. Argentina Market Analysis
      • 13.8.3.1. Introduction
      • 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.3.2.1. By Reagent Kits
        • 13.8.3.2.2. By Disease
        • 13.8.3.2.3. By End User

14. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. Italy
      • 14.3.1.3. France
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. BENELUX
      • 14.3.1.7. Russia
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Reagent Kits
    • 14.3.3. By Disease
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Reagent Kits
    • 14.4.3. By Disease
    • 14.4.4. By End User
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Germany Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Reagent Kits
        • 14.8.1.2.2. By Disease
        • 14.8.1.2.3. By End User
    • 14.8.2. Italy Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Reagent Kits
        • 14.8.2.2.2. By Disease
        • 14.8.2.2.3. By End User
    • 14.8.3. France Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Reagent Kits
        • 14.8.3.2.2. By Disease
        • 14.8.3.2.3. By End User
    • 14.8.4. U.K. Market Analysis
      • 14.8.4.1. Introduction
      • 14.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.4.2.1. By Reagent Kits
        • 14.8.4.2.2. By Disease
        • 14.8.4.2.3. By End User
    • 14.8.5. Spain Market Analysis
      • 14.8.5.1. Introduction
      • 14.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.5.2.1. By Reagent Kits
        • 14.8.5.2.2. By Disease
        • 14.8.5.2.3. By End User
    • 14.8.6. BENELUX Market Analysis
      • 14.8.6.1. Introduction
      • 14.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.6.2.1. By Reagent Kits
        • 14.8.6.2.2. By Disease
        • 14.8.6.2.3. By End User
    • 14.8.7. Russia Market Analysis
      • 14.8.7.1. Introduction
      • 14.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.7.2.1. By Reagent Kits
        • 14.8.7.2.2. By Disease
        • 14.8.7.2.3. By End User

15. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. China
      • 15.3.1.2. Japan
      • 15.3.1.3. South Korea
    • 15.3.2. By Reagent Kits
    • 15.3.3. By Disease
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Reagent Kits
    • 15.4.3. By Disease
    • 15.4.4. By End User
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. China Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Reagent Kits
        • 15.8.1.2.2. By Disease
        • 15.8.1.2.3. By End User
    • 15.8.2. Japan Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Reagent Kits
        • 15.8.2.2.2. By Disease
        • 15.8.2.2.3. By End User
    • 15.8.3. South Korea Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Reagent Kits
        • 15.8.3.2.2. By Disease
        • 15.8.3.2.3. By End User

16. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Indonesia
      • 16.3.1.3. Malaysia
      • 16.3.1.4. Thailand
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Reagent Kits
    • 16.3.3. By Disease
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Reagent Kits
    • 16.4.2. By Disease
    • 16.4.3. By End User
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. India Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Reagent Kits
        • 16.8.1.2.2. By Disease
        • 16.8.1.2.3. By End User
    • 16.8.2. Indonesia Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Reagent Kits
        • 16.8.2.2.2. By Disease
        • 16.8.2.2.3. By End User
    • 16.8.3. Malaysia Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Reagent Kits
        • 16.8.3.2.2. By Disease
        • 16.8.3.2.3. By End User
    • 16.8.4. Thailand Market Analysis
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.4.2.1. By Reagent Kits
        • 16.8.4.2.2. By Disease
        • 16.8.4.2.3. By End User

17. Oceania Market 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Reagent Kits
    • 17.3.3. By Disease
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Reagent Kits
    • 17.4.2. By Disease
    • 17.4.3. By End User
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. Australia Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Reagent Kits
        • 17.8.1.2.2. By Disease
        • 17.8.1.2.3. By End User
    • 17.8.2. New Zealand Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Reagent Kits
        • 17.8.2.2.2. By Disease
        • 17.8.2.2.3. By End User

18. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkiye
      • 18.3.1.3. North Africa
      • 18.3.1.4. South Africa
      • 18.3.1.5. Rest of Middle East and Africa
    • 18.3.2. By Reagent Kits
    • 18.3.3. By Disease
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Reagent Kits
    • 18.4.3. By Disease
    • 18.4.4. By End User
  • 18.5. Market Trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. GCC Countries Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Reagent Kits
        • 18.8.1.2.2. By Disease
        • 18.8.1.2.3. By End User
    • 18.8.2. Turkiye Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Reagent Kits
        • 18.8.2.2.2. By Disease
        • 18.8.2.2.3. By End User
    • 18.8.3. South Africa Market Analysis
      • 18.8.3.1. Introduction
      • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.3.2.1. By Reagent Kits
        • 18.8.3.2.2. By Disease
        • 18.8.3.2.3. By End User
    • 18.8.4. North Africa Market Analysis
      • 18.8.4.1. Introduction
      • 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.4.2.1. By Reagent Kits
        • 18.8.4.2.2. By Disease
        • 18.8.4.2.3. By End User

19. Market Structure Analysis

  • 19.1. Market Analysis by Tier of Companies
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Market Presence Analysis

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Branding and Promotional Strategies
  • 20.3. Key Development Analysis
  • 20.4. Competition Deep Dive
    • 20.4.1. HiMedia Laboratories
      • 20.4.1.1. Overview
      • 20.4.1.2. Product Portfolio
      • 20.4.1.3. Sales Footprint
      • 20.4.1.4. Key Financials
      • 20.4.1.5. SWOT Analysis
      • 20.4.1.6. Strategy Overview
        • 20.4.1.6.1. Marketing Strategy
        • 20.4.1.6.2. Product Strategy
        • 20.4.1.6.3. Channel Strategy
    • 20.4.2. HiMedia Laboratories
      • 20.4.2.1. Overview
      • 20.4.2.2. Product Portfolio
      • 20.4.2.3. Sales Footprint
      • 20.4.2.4. Key Financials
      • 20.4.2.5. SWOT Analysis
      • 20.4.2.6. Strategy Overview
        • 20.4.2.6.1. Marketing Strategy
        • 20.4.2.6.2. Product Strategy
        • 20.4.2.6.3. Channel Strategy
    • 20.4.3. Speedy Assay Sdn Bhd
      • 20.4.3.1. Overview
      • 20.4.3.2. Product Portfolio
      • 20.4.3.3. Sales Footprint
      • 20.4.3.4. Key Financials
      • 20.4.3.5. SWOT Analysis
      • 20.4.3.6. Strategy Overview
        • 20.4.3.6.1. Marketing Strategy
        • 20.4.3.6.2. Product Strategy
        • 20.4.3.6.3. Channel Strategy
    • 20.4.4. REAGEN LLC
      • 20.4.4.1. Overview
      • 20.4.4.2. Product Portfolio
      • 20.4.4.3. Sales Footprint
      • 20.4.4.4. Key Financials
      • 20.4.4.5. SWOT Analysis
      • 20.4.4.6. Strategy Overview
        • 20.4.4.6.1. Marketing Strategy
        • 20.4.4.6.2. Product Strategy
        • 20.4.4.6.3. Channel Strategy
    • 20.4.5. FUJIKURA KASEI CO., LTD.
      • 20.4.5.1. Overview
      • 20.4.5.2. Product Portfolio
      • 20.4.5.3. Sales Footprint
      • 20.4.5.4. Key Financials
      • 20.4.5.5. SWOT Analysis
      • 20.4.5.6. Strategy Overview
        • 20.4.5.6.1. Marketing Strategy
        • 20.4.5.6.2. Product Strategy
        • 20.4.5.6.3. Channel Strategy
    • 20.4.6. GeneReach Biotechnology Corp.
      • 20.4.6.1. Overview
      • 20.4.6.2. Product Portfolio
      • 20.4.6.3. Sales Footprint
      • 20.4.6.4. Key Financials
      • 20.4.6.5. SWOT Analysis
      • 20.4.6.6. Strategy Overview
        • 20.4.6.6.1. Marketing Strategy
        • 20.4.6.6.2. Product Strategy
        • 20.4.6.6.3. Channel Strategy
    • 20.4.7. Thermo Fisher Scientific
      • 20.4.7.1. Overview
      • 20.4.7.2. Product Portfolio
      • 20.4.7.3. Sales Footprint
      • 20.4.7.4. Key Financials
      • 20.4.7.5. SWOT Analysis
      • 20.4.7.6. Strategy Overview
        • 20.4.7.6.1. Marketing Strategy
        • 20.4.7.6.2. Product Strategy
        • 20.4.7.6.3. Channel Strategy
    • 20.4.8. Lab - Ind Resource Sdn Bhd.
      • 20.4.8.1. Overview
      • 20.4.8.2. Product Portfolio
      • 20.4.8.3. Sales Footprint
      • 20.4.8.4. Key Financials
      • 20.4.8.5. SWOT Analysis
      • 20.4.8.6. Strategy Overview
        • 20.4.8.6.1. Marketing Strategy
        • 20.4.8.6.2. Product Strategy
        • 20.4.8.6.3. Channel Strategy
    • 20.4.9. SUREBIO
      • 20.4.9.1. Overview
      • 20.4.9.2. Product Portfolio
      • 20.4.9.3. Sales Footprint
      • 20.4.9.4. Key Financials
      • 20.4.9.5. SWOT Analysis
      • 20.4.9.6. Strategy Overview
        • 20.4.9.6.1. Marketing Strategy
        • 20.4.9.6.2. Product Strategy
        • 20.4.9.6.3. Channel Strategy
    • 20.4.10. Auro Biotechnologies Pvt. Ltd.
      • 20.4.10.1. Overview
      • 20.4.10.2. Product Portfolio
      • 20.4.10.3. Sales Footprint
      • 20.4.10.4. Key Financials
      • 20.4.10.5. SWOT Analysis
      • 20.4.10.6. Strategy Overview
        • 20.4.10.6.1. Marketing Strategy
        • 20.4.10.6.2. Product Strategy
        • 20.4.10.6.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology